B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ATP2A3

MOLECULAR TARGET

ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3

UniProt: Q93084NCBI Gene: 4891 compounds

ATP2A3 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ATP2A3

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1paxilline0.691

About ATP2A3 as a Drug Target

ATP2A3 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented ATP2A3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ATP2A3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.